All Companies
Ticker RNAZ
We can't analyze this yet — its market data looks wrong
You reached the page — here's exactly what RNAZ is, and why it's out of scope for now.
What this ticker is
RNAZ
Transcode Therapeutics Inc.
NASDAQ
Healthcare
Biotechnology
Why we can't analyze it yet
Data provider – reported cap ($3,429,478) is 7.8× off vs SEC filings (16,930,739 shares × $1.57 ≈ $26,581,260); source data unreliable
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
data_corrupt